South Africa Sepsis Diagnostics Market Size & Outlook

The sepsis diagnostics market in South Africa is expected to reach a projected revenue of US$ 10.9 million by 2030. A compound annual growth rate of 6.4% is expected of South Africa sepsis diagnostics market from 2023 to 2030.
Revenue, 2022 (US$M)
$6.6
Forecast, 2030 (US$M)
$10.9
CAGR, 2023 - 2030
6.5%
Report Coverage
South Africa

South Africa sepsis diagnostics market, 2018-2030 (US$M)

South

South Africa sepsis diagnostics market highlights

  • The South Africa sepsis diagnostics market generated a revenue of USD 6.6 million in 2022 and is expected to reach USD 10.9 million by 2030.
  • The South Africa market is expected to grow at a CAGR of 6.4% from 2023 to 2030.
  • In terms of segment, blood culture media was the largest revenue generating product in 2022.
  • Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Sepsis diagnostics market data book summary

Market revenue in 2022USD 6.6 million
Market revenue in 2030USD 10.9 million
Growth rate6.4% (CAGR from 2022 to 2030)
Largest segmentBlood culture media
Fastest growing segmentAssay Kits & Reagents
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Blood Culture Media, Assay Kits & Reagents, Software
Key market players worldwideBD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.7% of the global sepsis diagnostics market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 14.5 million by 2030.

Blood culture media was the largest segment with a revenue share of 39.39% in 2022. Horizon Databook has segmented the South Africa sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.


The sepsis diagnostics market in South Africa is primarily driven by the high prevalence of infectious diseases, such as HIV/AIDS and tuberculosis, which elevate the risk of sepsis. Increasing awareness of sepsis and its critical health impact also fuels market growth.

The South African market is predominantly characterized by laboratory-based tests, including blood cultures, microbiology assays, and serological tests, which typically require several hours to days for results.

However, there is a growing demand for point-of-care diagnostic tests, such as Procalcitonin (PCT) & C-Reactive Protein (CRP) tests, which offer rapid results and facilitate swift treatment decisions. This shift toward more immediate diagnostic solutions is expected to influence the market in the near future significantly.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sepsis Diagnostics Market Companies

Name Profile # Employees HQ Website

South Africa sepsis diagnostics market size, by product, 2018-2030 (US$M)

South Africa Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)

South Africa sepsis diagnostics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more